Grace Jiang

Grace Jiang is an accomplished professional with extensive experience in regulatory affairs within the biotechnology and healthcare sectors. Currently serving as the Head of Regulatory Affairs for Oncology at Vir Biotechnology, Inc., Grace Jiang holds a vice president title and is a member of the executive leadership team. Previously, leadership roles include Head of Regulatory Affairs overseeing Clinical Quality at Amunix, a Sanofi Company, and Head of US Regulatory Affairs for Cell Therapy at Gracell Biotechnologies, a member of AstraZeneca. Additionally, Grace Jiang contributes to the community as a member of the Board of Directors at Meadows Art and Technology Elementary School.